Prellis Biologics' Convertible Note Round

Prellis Biologics raised a round of funding on February 07, 2018. Investors include SOSV.

Prellis Biologics is developing technology to 3D print engineered human tissues and organs. With its sub-micrometer printing resolution, Prellis Biologics can create single layers of cells and build t…

Articles about Prellis Biologics' Convertible Note Round: